High concentrations of retinoids induce differentiation and late apoptosis in pancreatic cancer cells in vitro

Cancer Biology and Therapy

Volumn 4, Issue 5, 2005, Pages 602-611

  El Metwally, Tarek H ^a,b,f   Hussein, Mahmoud R ^c   Pour, Parviz M ^d,e   Kuszynski, Charles A ^b   Adrian, Thomas E ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d ASSIUT UNIVERSITY   (Egypt)

^e Assiut University   (Egypt)

^f Assiut University Faculty of Medicine   (Egypt)

Author keywords

Apoptosis; Pancreatic cancer; Retinoic acid

Indexed keywords

CARBONATE DEHYDRATASE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MUCIN; RECEPTOR BLOCKING AGENT; RETINOIC ACID RECEPTOR ALPHA; RETINOID; RO 415253; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

AEROBIC METABOLISM; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; BIOASSAY; CANCER CELL CULTURE; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; ELECTRON MICROSCOPY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HYPOTHESIS; IN VITRO STUDY; MICROSCOPY; NICK END LABELING; PANCREAS CANCER; PHENOTYPE; RECEPTOR DENSITY; RECEPTOR UPREGULATION;

EID: 25144444831     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.4.5.1762     Document Type: Article

References (63)

1. Rosenberg L. Pancreatic cancer. A review of emerging therapies. Drugs 2000; 59:1071-89.
2. Sakorafas GH, Tsiotou AG, Tsiotos GG. Molecular biology of pancreatic cancer; oncogenes, tumor suppressor genes, growth factors, and their receptors from a clinical perspective. Cancer Treat Rev 2000; 26:29-52.
3. Overholser JP, Prewett MC, Hooper AT, Waksal HW, Hicklin DJ. Epidermal growth factor receptor blockade by antibody IMC-C225 inhibits growth of a human pancreatic carcinoma xenograft in nude mice. Cancer 2000; 89:74-82.
4. Birk D, Gansauge F, Gansauge S, Formentini A, Lucht A, Beger HG. Serum and correspondent tissue measurements of epidermal growth factor (EGF) and epidermal growth factor receptor (EGF-R). Clinical relevance in pancreatic cancer and chronic pancreatitis. Int J Pancreatol 1999; 25:89-96.
5. Friess H, Buchler P, Berberat P, Kleeff J, Korc M, Buchler MW. Pancreatic cancer: Growth factors and growth factor receptors. In: Johnson CD, Imrie CW, eds. Pancreatic disease towards the year 2000. London: Springer-Verlag Ltd., 1999:299-309.
6. Offterdinger M, Schneider SM, Huber H, Grunt TW. Retinoids control the expression of c-erbB receptors in breast cancer cells. Biochem Biophys Res Commun 1998; 251:907-13.
7. Estival A, Clerc P, Vaysse N, Tam JP, Clemente F. Decreased expression of transforming growth factor-α during differentiation of human pancreatic cancer cells. Gastroenterology 1992; 103:1851-9.
8. Grandis JR, Zeng Q, Tweardy DJ. Retinoic acid normalized the increased gene transcription rate of TGF-α and EGFR in head and neck cancer cell lines. Nature Med 1996; 2:237-40.
9. Rozenblum E, Schutte M, Goggins M, et al. Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res 1997; 57:1731-4.
10. van Laethem J-L, Resibios A, Rickaert F, et al. Different expression of TGF-β1 in pancreatic ductal adenocarcinoma and cystic neoplasms. Pancreas 1997; 15:41-7.
11. Satoh K, Shimosegawa T, Hirota M, Koizumi M, Toyota T. Expression of transforming growth factor β1 and its receptors in pancreatic duct cell carcinoma and in chronic pancreatitis. Pancreas 1998; 16:468-74.
12. Hruban RH, Petersen GM, HA PK, Kern SE. Genetics of pancreatic cancer. From genes to families. Surg Oncol Clin N Am 1998; 7:1-23.
13. Falk LA, De Benedetti F, Lohrey N, Birchenall-Roberts MC, Ellingsworth LW, Faltynek CR, Ruscetti FW. Induction of transforming growth factor-β 1 (TGF-β 1), receptor expression and TGF-β 1 protein production in retinoic acid-treated HL-60 cells: possible TGF-β 1-mediated autocrine inhibition. Blood 1991; 77:1248-55.
14. waf1 expression and growth inhibition by transforming factor-β involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells. Cancer Res 1997; 57:3929-34.
15. Baldwin RL, Friess H, Yokoyama M, Lopez ME, Kobrin MS. Attenuated ALK5 receptor expression in human pancreatic cancer: Correlation with resistance to growth inhibition. Int J Cancer 1996; 67:283-8.
16. Freeman J, Venkatasubbarao K, Ahmed M, et al. Oncogenic ras downregulates the TGF-β type II receptor expression in pancreatic cancer. Proc Am Assoc Cancer Res 1998; 39:195.
17. Han G-R, Dohi DF, Lee H-Y, et al. All-trans retinoic acid increases TGF-β2 and insulin-like growth factor binding protein-3 expression through a retinoic acid receptor-a-dependent signaling pathway. J Biol Chem 1997; 272:13711-6.
18. Tachibana I, Imoto M, Adjei PN, et al. Overexpression of the TGF-β-regulated zinc finger encoding gene, TIEG, induces apoptosis in pancreatic epithelial cells. J Clin Invest 1997; 99:2365-74.
19. Yoshizawa M, Miyazaki H, Kojima S. Retinoids potentiate TGF-β in bovine endothelial cells through upregulating the expression of TGF-β receptors. J Cell Physiol 1998; 176:565-73.
20. Lu X-P, Fanjul A, Picard N, et al. Novel retinoid-related molecules as apoptosis inducers and effective inhibitors of human lung cancer cells in vivo. Nature Med 1997; 3:686-90.
21. El-Metwally TH, Adrian TE. Optimization of treatment conditions for studying the anticancer effects of retinoids using pancreatic adenocarcinoma as a model. Biochem Biophys Res Comm 1999; 257:596-603.
22. DiPaola RS, Aisner J. Overcoming Bcl-2- and p53-mediated resistance in prostate cancer. Semin Oncolg 1999; 26:112-6.
23. Eppinger TM, Buck J, Hammerling U. Growth control or terminal differentiation: Endogenous production and differential activities of vitamin A metabolites in HL-60 cells. J Exp Med 1993; 178:1995-2005.
24. Horn V, Minucci S, Ogryzko V, et al. RAR and RXR selective ligands cooperatively induce apoptosis and neuronal differentiation in P19 embryonal carcinoma cells. FASEB J 1996; 10:1071-7.
25. Lotan R. Retinoids and apoptosis: Implications for cancer chemoprevention and therapy. J Natl Cancer Inst 1995; 87:1655-7.
26. King KL, Cidlowski JA. Cell cycle regulation and apoptosis. Annu Rev Physiol 1998; 60:601-17.
27. Thompson B. Special topic: Apoptosis. Annu Rev Physiol 1998; 60:525-31.
28. Masmann TR. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol 1983; 65:55-63.
29. Armstrong J McD, Myers DV, Verpoorte JA, Edsall JT. Purification and properties of human erythrocyte carbonic anhydrase. J Biol Chem 1966; 241:5137-49.
30. Plucinsky MC, Riley WM, Prprok JJ, Alhadeff JA. Total and lipid-associated serum sialic acid levels in cancer patients with different primary sites and differing degrees of metastatic involvement. Cancer 1986; 58:2680-5.
31. Garrigue-Antar L, Barbieux I, Lieubeau B, Boisteau O, Gregoire M. Optimization of CCL64-based bioassay for TGF-β. J Immunol Methods 1995; 186:267-74.
32. Skullman S, Adrian TE, Permert J, Larsson J. Humoral growth factors in plasma and liver tissue during liver regeneration and malnutrition. Eur J Gastroenterol Hepatol 1994; 6:797-802.
33. Waters CM, Oberg KC, Carpenter G, Overholser KA. Rate constant for binding, dissociation and internalization of EGF: Effect of receptor occupancy and ligand concentration. Biochemistry 1990; 29:3563-9.
34. Toma S, Isnardi L, Raffo P, et al. Effects of all-trans retinoic acid and 13-cis retinoic acid on breast cancer cell lines: Growth inhibition and apoptosis induction. Int J Cancer 1997; 70:619-27.
35. Hong WK, Sporn MB. Recent advances in chemoprevention of cancer. Science 1997; 278:1073-7.
36. Nakagawa K, Sogo S, Hioki K, Tokunaga R, Taketani S. Acquisition of cell adhesion and induction of focal adhesion kinase of human colon cancer Colo 201 cells by retinoic acid-induced differentiation. Differentiation 1998; 62:249-57.
37. Bryant G, Haberern C, Rao CN, Liotta LA. Butyrate induced reduction of tumor cell laminin receptors. Cancer Res 1986; 46:807-11.
38. Iovanna JL. Redifferentiation and apoptosis of pancreatic cells during acute pancreatitis. Int J Pancreatol 1996; 20:77-84.
39. Renault E, Sarrazin S, Deschatrette J. Evidence for interactions between rat hepatoma cell apoptosis and differentiation. Biochem Genet 1998; 36:1-13.
40. Hass R. Retrodifferentiation and cell death. Crit Rev Oncog 1994; 5:359-71.
41. Wang Y, He H, Zigler J, et al. bFGF suppresses serum-deprivation-induced apoptosis in a human lens epithelial cell line. Exp Cell Res 1999; 249:123-30.
42. Tian X, Pang J, To S, Ng H. Restoration of wild-type PTEN expression leads to apoptosis, induces differentiation and reduces telomerase activity in human glioma cells. J Neuropathol Exp Neurol 1999; 58:472-9.
43. Mahieu I, Becq F, Wolfensberger T, et al. The expression of carbonic anhydrase II and IV in the human pancreatic cancer cell line Capan-1 is associated with bicarbonate ion channels. Biol Cell 1994; 81:131-41.
44. Frazier ML, Lilly BJ, Wu EF, Ota T, Hewett-Emmett D. Carbonic anhydrase gene expression in cell lines from human pancreatic adenocarcinoma. Pancreas 1990; 5:507-14.
45. Lomri A, Baron R. 1-α,25-dihydroxy-vitamin D3 regulates the transcription of carbonic anhydrase II mRNA in avian myelo-monocytes. Cell Biol 1992; 89:4688-92.
46. Quelo I, Jurdic P. Differential regulation of the carbonic anhydrase II gene expression by hormonal nuclear receptors in monocytic cells: Identification of the retinoic acid response element. Biochem Biophys Res Commun 2000; 271:481-91.
47. Hatake K, Tomizuka H, Ikeda M, Terui Y, Miura Y. Apoptosis-gene expression in hematopoietic system: Normal and pathological conditions. Int J Mol Med 1998; 1:121-9.
48. Studzinski GP, Harrison LE. Differentiation-related changes in the cell cycle traverse. Int Rev Cytolo 1999; 189:1-58.
49. Choudhury A, Singh RK, Moniaux N, El-Metwally TH, Aubert JP, Batra SK. Retinoic acid-dependent TGF-β2-mediated induction of MUC4 mucin expression in human pancreatic tumor cells follows RAR-α signaling pathway. J Biol Chem 2000; 275:33929-36.
50. Koo J, Jetten A, Belloni P, et al. Role of retinoid receptors in the regulation of mucin gene expression by retinoic acid in human tracheobronchial epithelial cells. Biochem J 1999; 338:351-7.
51. Lang D, Miknyoczki SJ, Huang L, Ruggeri BA. Stable reintroduction of wild type p53 (MTmp53ts) causes the induction of apoptosis and neuroendocrine-like differentiation in human ductal pancreatic carcinoma cells. Oncogene 1998; 16:1593-602.
52. Egawa N, Maillet B, VanDamme B, De Greve J, Kloppel G. Differentiation of pancreatic carcinoma induced by retinoic acid or sodium butyrate: A morphological and molecular analysis of four cell lines. Verchows Arch 1996; 429:59-68.
53. Chen CS, Mrksich M, Huang S, Whitesides GM, Ingber DE. Geometric control of cell life and death. Science 1997; 276:1425-8.
54. Rosewicz S, Wollbergs K, Von Lampe B, Matthes H, Kaiser A, Riecken EO. Retinoids inhibit adhesion to laminin in human pancreatic carcinoma cells via the alpha 6 beta 1-integrin receptor. Gastroenterology 1997; 112:532-42.
55. Moghal N, Neel BG. Integration of growth factor, extracellular matrix, and retinoid signals during bronchial epithelial cell differentiation. Mol Cell Biol 1998; 18:6666-78.
56. Heerdt BG, Houston MA, Augenlicht LH. Short-chain fatty acid-initiated cell cycle arrest and apoptosis of colonic epithelial cells is linked to mitochondrial function. Cell Growth Differ 1997; 8:523-32.
57. Liu Y, Peterson DA, Kimura H, Schubert D. Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J Neurochem 1997; 69:581-93.
58. Taipale J, Sharinen J, Keski-Oja J. Extracellular matrix-associated transforming growth factor-$: Role in cancer cell growth and invasion. Adv Cancer Res 1998; 87-134.
59. Fumatomi H, Itakura J, Ishiwata T, et al. Amphiregulin antisense oligonucleotide inhibits the growth of T3M4 human pancreatic cancer cells and sensitized the cells to EGF receptor-targeted therapy. Int J Cancer 1997; 72:512-7.
60. Murphy LO, Adrian TE. Amphiregulin but not TGF″ is a functional autocrine growth factor from human pancreatic cancer cells. Pancreas 1997; 15:447.
61. DiSilvestro P, Flanagan C, Angros L, Benbrook D. Decrease in Ki-67 and epidermal growth factor receptor expression correlates with retinoic acid induced growth inhibition in a cervical cancer cell line. Proc Am Assoc Cancer Res 1997; 38:88.
62. Grunt T, Dittrich E, Offerdinger M, et al. Retinoid-induced differentiation and apoptosis in breast cancer cells: Effects on c-erbB2 expression and cisplatin sensitivity. Proc Am Assoc Cancer Res 1998; 39:311.
63. Hudson LG, Santon JB, Glass CK, Gill GN. Ligand-activated thyroid hormone and retinoic acid receptors inhibit growth factor receptor promoter expression. Cell 1990; 62:1165-75.